ProspectIP Has Agreed Licensing Deals For Two Inventors And Products, A Device That Aims To Prevent (DVT) And A Safety Opener For Glass Vials, UK
Main Category: Blood / HematologyAlso Included In: Medical Devices / Diagnostics
Article Date: 01 Jun 2009 - 3:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
A University initiative to commercialise novel business ideas and inventions has secured its first two licensing agreements and attracted a further £400,000 in funding.
De Montfort University (DMU), Leicester, set up ProspectIP following a £2 million pilot funding award from the Higher Education Funding Council for England (HEFCE) in 2006. The project has already resulted in the launch of new products under direct contracts with entrepreneurs.
Now ProspectIP has agreed licensing deals for two inventors and their products, a device that aims to prevent Deep Vein Thrombosis (DVT) and a safety opener for glass vials.
The University has also secured £400,000 from the European Regional Development Fund to help support the scheme for the next two and a half years.
The licensing deals for both products have been agreed with British company Wallace Cameron Ltd. Based in Wishaw near Glasgow, the company provides first aid solutions for the travel, home and leisure industries and has established links with the healthcare, medical and consumer markets.
Inventor Noel McKenzie worked with ProspectIP to develop the Under-Foot Oscillator (U-FO) which aims to prevent Deep Vein Thrombosis in people seated for long periods of time by ensuring sufficient movement of blood up the legs.
The U-FO is a compact elliptical rocking device which can also be used to store complementary products such as compression socks. It is currently undergoing clinical testing.
Dr Anant Ghelani approached DMU to help with his invention for the safe opening of glass vials, widely used to store small amounts of medicines, drugs and other chemicals.
It is hoped the portable device could become part of the kit of any doctor, nurse or scientist to help reduce shattering accidents in hospitals and laboratories.
DMU experts created a commercialisation strategy for each product, working with the inventors on issues such as intellectual property, prototyping and market analysis before identifying and negotiating with the best licence partner.
Under the licensing agreements Wallace Cameron has exclusive rights to manufacture, distribute and sell the two products worldwide. The inventors will receive royalties on sales of the products.
Both inventions are expected to be on sale in late 2009.
Derek Palmer, Head of ProspectIP at DMU, said: "We are delighted to secure licence agreements for these inventors. Wallace Cameron is the ideal partner with the contacts and experience to help these products reach their full potential.
"The invention process is long and complex and many great business ideas don't progress because of a lack of expertise, investment or fragmented support. We help develop latent intellectual property and boost economic activity by supporting inventors through the whole commercialisation process."
Giovanni Benedetti, Group Chairman of Benedetti International Ltd, the holding company of Wallace Cameron, said: "Our product design division is delighted to work in conjunction with DMU and both inventors. The combination of DMU, the resource facilities of Benedetti International, shared product knowledge, innovative design and Wallace Cameron's network of sales and marketing resource will lead to a successful commercial launch of these new products.
"Our aim is to work further with universities and inventors to bring a strong commercial element to academics and enable commercial success for idea and inventions, so we can offer a large and varied range of products. I'm certain this initial collaboration will be the start of many similar joint ventures between us and DMU."
Source
De Montfort University
Visit our blood / hematology section for the latest news on this subject.
MLA
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/152062.php>
APA
http://www.medicalnewstoday.com/releases/152062.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




